NORITATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Noritate, and what generic alternatives are available?
Noritate is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in NORITATE is metronidazole. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Noritate
A generic version of NORITATE was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for NORITATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Patent Applications: | 4,537 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NORITATE |
What excipients (inactive ingredients) are in NORITATE? | NORITATE excipients list |
DailyMed Link: | NORITATE at DailyMed |
Pharmacology for NORITATE
Drug Class | Nitroimidazole Antimicrobial |
Anatomical Therapeutic Chemical (ATC) Classes for NORITATE
US Patents and Regulatory Information for NORITATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | NORITATE | metronidazole | CREAM;TOPICAL | 020743-001 | Sep 26, 1997 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |